Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital
Abstract Neurofibromatosis type 1 (NF1) is a genetic multisystem disorder. Clinicians must be aware of the diverse clinical features of this disorder in order to provide optimal care for it. We have set up an NF1 in-hospital medical care network of specialists regardless of patient age, launching a...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/dca033207aef4ba5accb41d21df64b1d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:dca033207aef4ba5accb41d21df64b1d |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:dca033207aef4ba5accb41d21df64b1d2021-12-02T17:52:12ZEstablishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital10.1038/s41598-021-91345-62045-2322https://doaj.org/article/dca033207aef4ba5accb41d21df64b1d2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91345-6https://doaj.org/toc/2045-2322Abstract Neurofibromatosis type 1 (NF1) is a genetic multisystem disorder. Clinicians must be aware of the diverse clinical features of this disorder in order to provide optimal care for it. We have set up an NF1 in-hospital medical care network of specialists regardless of patient age, launching a multidisciplinary approach to the disease for the first time in Japan. From January 2014 to December 2020, 246 patients were enrolled in the NF1 patient list and medical records. Mean age was 26.0 years ranging from 3 months to 80 years. The number of patients was higher as age at first visit was lower. There were 107 males (41%) and 139 females. After 2011, the number of patients has increased since the year when the medical care network was started. Regarding orthopedic signs, scoliosis was present in 60 cases (26%), and bone abnormalities in the upper arm, forearm, and tibia in 8 cases (3.5%). Neurofibromas other than cutaneous neurofibromas were present in 90 cases (39%), and MPNST in 17 cases (7.4%). We launched a multidisciplinary NF1 clinic system for the first time in Japan. For patients with NF1, which is a hereditary and systemic disease associated with a high incidence of malignant tumors, it will be of great benefit when the number of such clinics in Japan and the rest of Asia is increased.Yoshihiro NishidaKunihiro IkutaAtsushi NatsumeNaoko IshiharaMaki MorikawaHiroyuki KidokoroYukako MuramatsuNorie NonobeKanako IshizukaTakuya TakeichiMiki KanbeSeiji MizunoShiro ImagamaNorio OzakiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yoshihiro Nishida Kunihiro Ikuta Atsushi Natsume Naoko Ishihara Maki Morikawa Hiroyuki Kidokoro Yukako Muramatsu Norie Nonobe Kanako Ishizuka Takuya Takeichi Miki Kanbe Seiji Mizuno Shiro Imagama Norio Ozaki Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital |
| description |
Abstract Neurofibromatosis type 1 (NF1) is a genetic multisystem disorder. Clinicians must be aware of the diverse clinical features of this disorder in order to provide optimal care for it. We have set up an NF1 in-hospital medical care network of specialists regardless of patient age, launching a multidisciplinary approach to the disease for the first time in Japan. From January 2014 to December 2020, 246 patients were enrolled in the NF1 patient list and medical records. Mean age was 26.0 years ranging from 3 months to 80 years. The number of patients was higher as age at first visit was lower. There were 107 males (41%) and 139 females. After 2011, the number of patients has increased since the year when the medical care network was started. Regarding orthopedic signs, scoliosis was present in 60 cases (26%), and bone abnormalities in the upper arm, forearm, and tibia in 8 cases (3.5%). Neurofibromas other than cutaneous neurofibromas were present in 90 cases (39%), and MPNST in 17 cases (7.4%). We launched a multidisciplinary NF1 clinic system for the first time in Japan. For patients with NF1, which is a hereditary and systemic disease associated with a high incidence of malignant tumors, it will be of great benefit when the number of such clinics in Japan and the rest of Asia is increased. |
| format |
article |
| author |
Yoshihiro Nishida Kunihiro Ikuta Atsushi Natsume Naoko Ishihara Maki Morikawa Hiroyuki Kidokoro Yukako Muramatsu Norie Nonobe Kanako Ishizuka Takuya Takeichi Miki Kanbe Seiji Mizuno Shiro Imagama Norio Ozaki |
| author_facet |
Yoshihiro Nishida Kunihiro Ikuta Atsushi Natsume Naoko Ishihara Maki Morikawa Hiroyuki Kidokoro Yukako Muramatsu Norie Nonobe Kanako Ishizuka Takuya Takeichi Miki Kanbe Seiji Mizuno Shiro Imagama Norio Ozaki |
| author_sort |
Yoshihiro Nishida |
| title |
Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital |
| title_short |
Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital |
| title_full |
Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital |
| title_fullStr |
Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital |
| title_full_unstemmed |
Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital |
| title_sort |
establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in nagoya university hospital |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/dca033207aef4ba5accb41d21df64b1d |
| work_keys_str_mv |
AT yoshihironishida establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT kunihiroikuta establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT atsushinatsume establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT naokoishihara establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT makimorikawa establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT hiroyukikidokoro establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT yukakomuramatsu establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT norienonobe establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT kanakoishizuka establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT takuyatakeichi establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT mikikanbe establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT seijimizuno establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT shiroimagama establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital AT norioozaki establishmentofinhospitalclinicalnetworkforpatientswithneurofibromatosistype1innagoyauniversityhospital |
| _version_ |
1718379256445140992 |